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Abstract
Background: Nosocomial transmission has been implicated as a key factor in the outbreak of extensively drug resistant
(XDR) and multidrug-resistant (MDR-TB) tuberculosis at Church of Scotland Hospital (CoSH), in KwaZulu-Natal (KZN), South
Africa. The aim of this study was to quantify the burden of potentially infectious tuberculosis and the proportion of drug
resistance among hospital inpatients throughout the province of KZN.
Methods: Inpatients with current cough, capable of producing sputum were selected from 19 public hospitals in KZN. After
informed consent, demographic and clinical data, and sputum samples were collected. Samples were processed for
fluorescent microscopy, liquid culture and first and second-line anti-tuberculosis drug susceptibility testing.
Results: There were a total of 2,964 inpatients where sampling was done. About 1,585 inpatients (53%) had a current cough
and sufficient microbiological and clinical data for inclusion. Mycobacterium tuberculosis was isolated from 543 inpatients
(34% of those tested and 18% of all inpatients). Eighty-four (15%) inpatients with TB were found to be MDR-TB infected and
16 (3%) had XDR-TB. There was no association between the prevalence of MDR-TB and proximity to CoSH. Among patients
with microbiologically confirmed TB, MDR/XDR-TB was associated with male sex, a longer length of stay between hospital
admission and date of sample collection, and current or previous TB treatment.
Conclusions: One in five inpatients had potentially infectious TB. This is an underestimate since patients without current
cough were not tested. MDR-TB was frequently observed and was found in nearly one in six active TB inpatients. While
present at lower levels than the original outbreak report at CoSH, XDR-TB was detected in hospitals throughout KZN. The
high burden of potentially infectious TB and confirmed MDR-TB, much of it undiagnosed, indicates a serious risk for
nosocomial transmission and the need for intensified infection control within the inpatient setting.
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Introduction
HIV has had a huge impact on the incidence of tuberculosis
(TB) cases in sub-Saharan Africa [1]. South Africa has an
estimated adult HIV prevalence of 17.9% in 2012 [2] andthe
estimated incidence of TB has risen from 317 to 1000/100,000
population between 1995 and 2012 [3]. In 2012 65% of HIV
tested tuberculosis cases were co-infected with HIV [3] and
together these two pathogens are responsible for an estimated 46%
of disability-adjusted life years (DALY) lost in South Africa [1].
While the HIV epidemic alone has complicated local responses
and increased resource demands on an already strained public
health system, the spread of drug-resistant TB (DR-TB) within
South Africa constitutes an additional challenge to effective control
of the disease.
Based on data from the most recent national Drug Resistance
Survey in 2002, South Africa had an estimated burden of
approximately 13,000 multidrug-resistant TB (MDR-TB) cases
[4]. MDR-TB is defined as resistant to isoniazid and rifampin.
This MDR-TB burden places South Africa on the 5th position
among countries with the highest global incidence of MDR-TB
after China, India, Russian Federation, and Pakistan in terms of
absolute numbers [5]. The top four countries have an estimated
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HIV prevalence of less than 1% compared to South Africa where
the HIV prevalence is estimated to be 17.9% [2]. The urgency of
addressing DR-TB emergence in a high HIV prevalence setting
was underscored by the report of an outbreak of extensively drug-
resistant TB (XDR-TB) in Tugela Ferry centered in and around
the Church of Scotland Hospital (CoSH) in the Msinga sub-district
of KwaZulu-Natal (KZN) [6]. XDR-TB is a form of MDR-TB
that is additionally resistant to a fluoroquinolone and either
amikacin, kanamycin or capreomycin and is associated with a high
mortality [6]. Subsequent analysis identified evidence for a
substantial role of nosocomial transmission in this highly
publicized XDR-TB outbreak [7,8].
The role of healthcare institutions in the propagation of TB, and
highly-drug resistant tuberculosis, in South Africa is not clear.
While the Tugela Ferry outbreak provides a concrete example of
how the concentration of immuno-suppressed patients on open
wards can facilitate the spread of tuberculosis and DR-TB in
particular, the more general role of nosocomial transmission in the
transmission and amplification of DR-TB requires further study.
Does CoSH represent a unique infection control phenomenon, or
does it represent a more general problem in KZN? Previous
studies have documented a large burden of potentially infectious
TB among inpatients [9] and undiagnosed TB among patients
dying at Edendale Hospital, located in the Msunduzi sub-district
of KZN [10].
In this study we aim to quantify the burden of potentially
infectious TB within hospital settings throughout the KZN
Province, to estimate the proportion of inpatients with DR-TB,
and to identify risk factors for drug resistance among these
potential sources of nosocomial TB transmission.
Methods
Study Setting
KZN is the second most populated province in South Africa
with a population of over 10 million, just over 20% of the total
South African overall population. In 2012, the incidence of TB in
South Africa was 1,000/100,000 with the highest burden of
tuberculosis in KZN [3]. The HIV prevalence among antenatal
clinic attendees is over 37.4%[11].
KZN is divided into 11 health districts and has 74 public
hospitals. It was not feasible to include all public hospitals in this
study. The study was, therefore, restricted to larger public
hospitals (.200 inpatient beds) that admitted general medical
patients. TB or referral/specialist hospitals were excluded. Thirty-
eight hospitals met these broad inclusion criteria. Given logistical
and resource constraints, we further reduced the number of
hospitals to be included in our study. In order to describe possible
local extension of XDR-TB, the nine eligible hospitals in closest
proximity to Church of Scotland were selected and, in order to
examine the burden of resistance in the rest of the province, an
additional nine hospitals were randomly selected from the rest of
the study area (Figure 1). Each of these 18 hospitals was sampled at
two separate time points which allowed us to test for temporal
changes in the proportion of disease that was resistant within these
settings (Phase 1: August 2007 to August 2008 and Phase 2: August
2009 to November 2009). One additional hospital (Benedictine)
was included only in Phase 2 of the study.
Study Population
Participant enrolment was conducted at each selected facility on
a single day during each of the two phases of the study. Adult
inpatients (at least 18 years old) on medical wards, TB wards,
isolation wards and in some cases from surgical wards (where
patients had been moved due to scarcity of beds in medical wards)
were screened for inclusion in the study. Any patient reporting a
cough on the day of the survey (regardless of other conditions or
the reason for admission to hospital) and who could provide
informed consent was enrolled. Thus the study population
consisted of inpatients with unsuspected TB, suspected TB and
diagnosed TB. Participants were sampled regardless of whether
they had initiated TB chemotherapy. After written informed
consent was obtained, using a consent form approved by the
Biomedical Research Committee of the University of KwaZulu-
Natal, participants were given containers to collect sputum in the
early hours of the following day. For participants with an
unproductive cough, the sputum was induced with hypertonic
saline. The study team collected samples following the local
infection control guidelines [12]. A standardized questionnaire
including demographic and clinical data was also administered by
trained field staff. Patients’ hospital records were reviewed for date
of admission, diagnosis, current treatment, microscopy results and
verification of HIV status.
Most of the selected hospitals lack respiratory isolation facilities
and the vast majority of the wards from which participants were
enrolled were open, shared space. Patients diagnosed with TB
during the course of this study were started on treatment and
transferred to TB-specific wards within these hospitals when
available, consistent with standard local practice.
TB culture and drug-susceptibility testing
Sputum samples were processed using N-acetyl-L-cysteine-
sodium hydroxide [13] and centrifugally concentrated for acid
fast bacilli smear examination and M. tuberculosis culture. The
concentrated pellet was suspended in 1.25 mls of buffer (pH 6.8)
following which 0.1 ml was placed on a microscope slide and
0.5 ml was cultured on both Middlebrook 7H11 selective agar
(Difco) and liquid medium (BACTEC MGIT 960, Becton
Dickenson Diagnostics). Positive cultures were confirmed as M.
tuberculosis using Niacin and Nitrate biochemical testing [13]. A
Middlebrook 7H10 agar (Difco), 1% proportion test of suscepti-
bility to isoniazid (H= 1 ug/ml), rifampicin (R= 1 ug/ml),
ethambutol(E = 7.5 ug/ml), streptomycin(S = 2 ug/ml), kanamy-
cin (K= 10 ug/ml), ofloxacin (O= 1 ug/ml), ethionomide
(ETH=5.0 ug/ml), capreomycin (C=5 ug/ml) was performed
on all M. tuberculosis confirmed cultures.
Specimens were classified as confirmed M. tuberculosis if either
7H11or MGIT was positive. Patients resistant to H and R (with or
without resistance to additional anti-tuberculosis drugs) were
classified as MDR-TB infected. Patients with MDR-TB and
additional resistance to O and the injectable K or C were classified
as XDR-TB infected. The prevalence rate of MDR- and XDR-TB
was calculated as a proportion of confirmed cases of TB.
Statistical methods
Data was double entered into EpiData (Odense, Denmark) from
paper records and statistical analyses were done using Stata
version 11.0 (College Station, TX, USA). Data was analysed using
commands in Stata Version 11.0 (College Station, TX, USA)
software which takes into account the cluster sampling design. We
first described the demographic and clinical characteristics of study
participants. We then reviewed the bacteriological results and used
a chi square test, adjusted for clustering by hospital, to test for
differences in the proportion of TB that was resistant by proximity
to CoSH and by Phase of the study. Finally, we identified factors
independently associated with MDR-TB among those with
detected TB using multivariate logistic regression. Our multivar-
iate model initially included all factors. Factors were eliminated
TB and MDR-TB among Inpatients in South Africa
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one by one starting with the least significant until all factors
remaining were significant (p-value,0.05).
Ethics Statement
The study received ethics approval from the University of
KwaZulu-Natal Biomedical Research Ethics Committee (BREC).
A patient information sheet and informed consent document was
approved by BREC for use in the study.
Results
There were a total of 2964 inpatients on the hospital wards on
the sampling days that were included in our study. We consented
and attempted to collect sputum specimens and clinical data from
a total of 1644 symptomatic inpatients at participating hospitals
(758 during Phase 1 and 886 during Phase 2). Fifty-nine potential
participants for whom we were missing clinical or microbiological
Figure 1. Proportion of Symptomatic Inpatients with Culture confirmed Tuberculosis and MDR-TB by hospital and District of
KwaZulu-Natal. Patients were defined as symptomatic if they were coughing on the day of sampling. The diameter of the circles representing
hospitals is proportional to the proportion of all culture positive patients with MDR-TB. The shading of the circles shows whether the hospitals were
adjacent to Church of Scotland Hospital (CoSH) at Tugela Ferry. The figures in brackets at each hospital indicate the proportion (%) of all sampled
patients who were culture positive and the proportion who had confirmed MDR-TB.
doi:10.1371/journal.pone.0090868.g001
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data were excluded from the analyses (57 during Phase 1 and 2
during Phase 2). In total, our analysis included data from 1,585
inpatients (which represented 53% of all inpatients).
Characteristics of the sample population
Most measured characteristics (sex, age, on TB treatment, TB
suspected, diagnosed with HIV) were similar among participants
in the two Phases of the study (Table 1).
The proportion of participants on treatment for TB at the time
of the survey was similar in both phases (51%). Of those on
treatment, 20% had initiated treatment before the current
admission, 31% at the time of admission and 48% at some point
between admission and time of data collection. A higher
proportion of participants had started treatment prior to admission
in the second Phase of our study compared with the first (24% vs
15%, p= 0.02). Of those on treatment for TB, most were taking a
standard first line fixed dose combination of RHZE or RH (83%)
and 21% were being treated with streptomycin.
Detection of M. tuberculosis among study participants
A case of tuberculosis was defined on the basis of the ability to
grow M. tuberculosis from sputum using either solid or liquid media.
From the 1,585 inpatients included in the analysis 543 (34%)
(Table 2) were found to be M. tuberculosis culture positive cases.
The yields from both phases were similiar (36% in Phase 1 and
33% in Phase 2). Auramine smear results were available for 542 of
the culture positive patients, and 317 (58%) of these were
auramine smear positive. In addition there were 59 patients who
were found to be smear positive but had negative cultures with
both culture media. The majority of these smear positive culture
negative patients, 39 (66%), were on tuberculosis therapy at the
time of sampling which could account for the discordance between
the two tests. Of participants not receiving TB treatment at the
time of sampling, a total of 26% were bacteriologically confirmed
TB. Of patients on treatment at the time of the survey, 42% still
had positive cultures and thus remained potential sources of
nosocomial transmission.
Multidrug resistance
Of the 543 positive MTB isolates, 472 (87%) had drug-
susceptibility results. Of the 71 without susceptibility results, 25
were contaminated, 27 did not regrow during drug susceptibility
testing, and 19 were not tested. Of 543 culture confirmed cases of
M tuberculosis, 84 specimens (15%; 95CI: 12%–20%) were
identified with MDR-TB (inclusive of XDR-TB). The proportion
of MDR-TB amongst culture positive patients was similar in
patients attending CoSH (13%), the eight facilities closest to CoSH
(13%) and the ten facilities further from COSH (18%), p = 0.1. In
total, 16 cases of XDR-TB were detected (3%; 95 CI: 2%–5%).
There was no difference in the proportion of XDR-TB among the
three geographic groups of facilities (p = 0.1) [Table 3]. However,
the proportion of MDR-TB at individual facilities varied
considerably from a high of 37% in Mosvold to a low of 4% in
Dundee (Figure 1).
Amongst the 472 participants with culture positive samples and
available susceptibility testing, 104 had resistance to any TB drug
(22%). Resistance to individual anti-TB drugs were as follows:
H= 96 (20.3%); R= 88 (18.6%); E= 68 (14.4%); S = 64 (13.6%);
ETH=33 (7.0%); O=20 (4.2%); K= 17 (3.6%) and C=14
(3.0%).
The proportion of cases with MDR-TB differed between newly
diagnosed patients (10%) and those previously treated for TB
(32%), p,0.001. The majority of MDR-TB patients were on some
form of TB treatment (85%) [Table 4]. The levels of mono-
resistance and poly-resistance to first line drugs were similar in new
and previously treated cases.
Factors independently associated with MDR among
those with TB
In a multivariate logistic regression model that adjusted for the
cluster study design, male sex [ORadj: 2.0; 95% CI: 1.4–3.1], a
longer time between hospital admission and date of sample
collection [ORadj: 1.1; 95% CI: 1.0–1.2] (a 10% increased odds of
MDR for every additional day of hospitalization), being currently
on TB treatment [ORadj: 2.5; 95%CI:1.4–4.5] and being treated
for TB before admission [ORadj: 3.5; 95%CI: 1.8–6.71] were




Age, (median, IQR) 1544 37(30–48)
Sex (male) 796 50%
On TB Treatment (yes) 811 51%
Cough
No cough 158 10%
,2 wks 308 19%
2–3 weeks 409 26%
4 or more 591 37%
Unknown 119 8%
TB Close contact (yes) 601 42%





.1 Hospital admission ,2 yrs 509 32%
.4 Outpatient visits ,2 yrs 817 52%
doi:10.1371/journal.pone.0090868.t001











The symbols Na and %b correspond to the total number and percentage of
sampled patients with the indicated result. Culturec is a composite result of
MGIT and 7H11 agar. Culture Positive refers to growth of M. tuberculosis on
either media, and culture other to negative on both media or no result. MDRd is
resitance to both rifampicin and isoniazid and is inclusive of XDR.
doi:10.1371/journal.pone.0090868.t002
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independently associated with MDR among those with TB
(Table 5).
Unrecognized and ineffectively treated tuberculosis in
the hospital setting
There were 199 patients with bacteriologically confirmed TB
that were not on TB treatment at the time of the survey. These
patients had already had a median length of stay in hospital of 3
days (IQR: 2–6) prior to the survey. Fourteen participants had
been in hospital for over 2 weeks at the time of the survey and 39%
reported a cough lasting 4 weeks or more. We isolated viable M.
tuberculosis from 344 patients that were on TB treatment at the time
of the survey. These patients already had a median length of stay
of 9 days in hospital (IQR: 5–19) and 49% reported having a
cough for 4 weeks or more. This corresponded to a median
duration of treatment of 7 days (IQR: 4–21) at the time of
sampling.
Of the 84 patients categorized as MDR-TB by drug suscepti-
bility testing conducted during the survey, only 8 were known to
the health facility to be MDR-TB patients at the time of the
sampling (10%). The remaining 76 participants with potentially
infectious MDR-TB (90%) had already spent a median of 7 days
(IQR: 4–22) in hospital with unrecognized MDR-TB. Of these, 14
participants had been in hospital for over a month. Almost half
reported a cough lasting four weeks or more.
Discussion
Outbreaks of TB and DR-TB within hospital settings have been
documented in diverse geographical settings [14–17]. In South
Africa, as in other settings where HIV infection is common among
inpatients and the background prevalence of TB is high, the risk of
nosocomial transmission of TB is likely to be amplified. As
demonstrated at CoSH, when immuno-suppressed patients on
open wards are exposed to other patients with unrecognized, or
inadequately treated, highly drug resistant strains of M. tuberculosis,
it is possible for large, highly lethal outbreaks to occur. Using a
mathematical model, Basu predicted that the number of XDR-TB
cases could increase five-fold in the absence of any intervention
and that more than half were likely to be nosocomial [8]. The
model also showed that clusters of initially nosocomial XDR-TB
could extend into the community [7]. While the tragic outbreak
and previous studies showing a high burden of TB among hospital
inpatients in KZN [9,10], it was not clear, at the time of initiating
this study whether the threat of nosocomial transmission of highly
drug resistant TB was generalized throughout the province.
In our survey, we found that nearly one in five inpatients (317)
on wards visited for this survey were smear and culture-positive
TB and posed a potential risk of transmitting disease within the
hospital. An additional 20 patients, not on therapy at the time of
sampling were smear positive but culture negative possibility due
to loss of viability during transit of the sample from the peripheral
hospitals. Since only patients with an active cough on the day of
the survey were sampled, this may actually underestimate the
burden of active disease on these wards. Out of 543 of all patients
with microbiological evidence of active TB, 344 (63%) were
already on treatment at the time of sampling for this survey. From
these participants receiving TB treatment, it was still possible to
detect M. tuberculosis from 42%. One possible reason for persistent
smear or culture positivity despite treatment is that these patients
had recently started their course of therapy and it was still too
early to detect any smear or culture conversion.
A second possibility for the persistence of smear or culture
positivity despite treatment is that these participants had DR-TB
that was not likely to respond to first-line treatment. It is
concerning that 90% of these patients with MDR-TB were not
Table 3. Proportion of Culture Positive and MDR-TB







location n n % n % n %
CoSHa 118 38 32% 5 13% 3 8%
Adjacent to CoSH 690 252 37% 34 13% 7 3%
Not adjacent to
CoSH
777 253 33% 45 18% 6 2%
Total 1585 543 34% 84 15% 16 3%
CoSHarefers to Church of Scotland Hospital at Tugela Ferry. Adjacent to CoSH
corresponds to 8 hospitals in sub-districts neighbouring CoSH. Not adjacent to
CoSH corresponds to 10 hospitals at locations not neighbouring CoSH. Culture
positive is the number and percentage of sampled individuals with culture
positive tuberculosis.
MDRbis the number and percentage of sampled individuals with rifampicin and
isoniazid resistance including XDR-TB.
doi:10.1371/journal.pone.0090868.t003
Table 4. Anti TB drug resistance profile of TB patients with Drug Susceptibility results.
New casea Previous Case
On Treatment On Treatment
Resistance Yes % No % Total % Yes % No % Total %
Pan Sensitive 137 84 107 91 244 85 79 60 28 68 107 62
Monoresistent 2 1 2 2 4 1 2 2 4 10 6 3
Polyresistent(not MDR) 2 1 2 2 4 1 3 2 2 5 5 3
MDR+XDR 23 14 6 5 29 10 48 36 7 17 55 32
XDR 5 3 2 2 7 2 9 7 0 0 9 5
Total 164 100 117 100 288 100 132 100 41 100 173 100
a11 patients had unknown previous treatment.
doi:10.1371/journal.pone.0090868.t004
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known to be infected with MDR-TB strains and could not have
been treated with appropriate therapy. The multivariate model
revealed strong associations between DR-TB and current or recent
treatment for TB among those participants in whom we found
viable M. tuberculosis at the time of survey; this is not unexpected as
treated TB cases without MDR-TB would likely have responded
and been culture negative at the time of the survey. The finding
that longer hospital stays were also associated with MDR-TB may
reflect persistent illness due to this resistant TB despite first-line
treatment and demonstrates that these patients with MDR-TB
may remain potential index cases in the wards for longer periods
of time than those with drug susceptible TB.
Our data suggest that the risk of active MDR-TB among
inpatients is a generalized threat throughout KZN and is not
confined to CoSH or to the hospitals in the areas in immediate
proximity to CoSH. While the proportion of MDR-TB varied
substantially between facilities and appears to be highest in the
northern health districts within KZN, we detected cases of active,
potentially infectious MDR-TB at each facility visited. In contrast
to the severity of MDR-TB throughout hospitals in KZN,
consistent with previous reports [18], XDR-TB appears to be
mainly concentrated in and around CoSH. We, however, found a
small percentage of cases with XDR-TB even at facilities far away
from the apparent epicenter of this outbreak. We note that these
cross-sectional surveys were done at each hospital on a single day
and that because of the high rates of patient turnover, this may not
reflect the prevalence of TB or DR-TB among inpatients over
longer periods of time. However the study was carried out in two
phases with consistent results during each phase indicating the
rates are likely to have been maintained during the study period
This study reveals a critical TB infection control challenge in
hospitals throughout KZN. The high frequency of microbiolog-
ically confirmed potentially infectious TB among inpatients, both
with drug susceptible and drug resistant forms of the disease, poses
a serious threat for patients and hospital workers in this province
[18]. The extent of the risk is hard to quantify exactly. Recent
studies attempting to measure aerosol production have found
considerable variability in culturable cough aerosols, even amongst
smear positive patients [19], and aerosol production does correlate
with recent transmission to household contacts [20]. It is also
unclear how quickly patients become non infectious after initiation
of therapy and 399 of the culture positive patients in this study had
been on treatment for a median of seven days. Early studies
suggested the infectiousness of patients with drug susceptible
tuberculosis declined dramatically within 2 weeks of initiating
therapy [21], but others have suggested that many smear positive
patients remain infectious for much longer [22]. However these
studies were carried out largely in the household contact setting
and the parameters determining transmission in an open ward,
between highly immune-compromised individuals have not be
determined but could include lower bacillary sputum burdens.
The WHO has stressed the importance of infection control in
strategies to improve TB control [23], but there are many
unanswered questions about how to implement an effective
infection control plan in an area with a disease burden as great
as in KZN. Particular challenges raised by our data include the
fact that nearly one in five participants in our study with a negative
sputum smear was eventually diagnosed with TB based on culture.
This suggests that the use of standard smear microscopy will likely
miss a substantial fraction of potential source cases, although it is
likely that these smear-negative, culture-positive cases are on
average less infectious [24]. New rapid diagnostic tools with high
sensitivity in HIV-infected inpatients, such as the GeneXpert test
will play a pivotal role in identifying cases earlier and reducing the
risk of nosocomial transmission. Additional approaches for
infection control, including the adoption of improved administra-
tive, environmental, and personal-protective measures are urgently
needed to address this hazard.
No single invention is likely to be effective in eliminating the
spread of TB in hospitals. However, a combination of mask use,
reduced hospitalization time, increased outpatient therapy,
improved ventilation, rapid drug testing, HIV treatment and
tuberculosis isolation facilities will likely begin to address the
challenge of nosocomial transmission [8]. While these changes will
Table 5. Analysis of factors associated with MDR.
Univariate results Multiple logisitic results
Variable n OR (95% CI) p value OR (95% CI) p value
Phase (ref = phase 1) 543 0.94 (0.55–1.60) 0.8
Sex (ref =male) 542 1.57 (1.05–2.36) 0.03 2.01 (1.41–3.13) 0.001
Age in increments of 5 years 527 0.95 (0.84–1.08) 0.42
Length of stay from Hospital admission to date
of sample collection in increments of one week
536 1.14 (1.03–1.27) 0.01 1.10 (1.00–1.20) 0.045
Currently on TB treat (ref = yes) 543 3.72 (2.16–6.42) ,0.001 2.52 (1.41–4.51) 0.004
Cough (ref = yes) 534 1.39 (0.54–3.52) 0.47
Duration of cough in increment of one month 487 1.04 (1.02–1.06) ,0.001
Treated for TB before admission (ref = yes) 522 3.95 (2.08–7.51) ,0.001 3.46 (1.78–6.73) 0.001
Last TB treatment completed (ref = No) 180 2.19 (0.96–4.99) 0.06
Last TB outcome (ref = not cured) 174 3.16 (1.40–7.14) 0.01
TB close contact (ref = Yes) 475 2.01 (1.24–3.25) 0.01
Number of times admitted to an hospital .1 (ref = 1 time) 543 1.19 (0.66–2.14) 0.5
Number of visits to any clinic or
OP dep. .4 (ref = 1–4 times)
543 1.53 (0.92–2.54) 0.1
Study Auramine Smear 542 1.68 (0.92–3.06) 0.09
doi:10.1371/journal.pone.0090868.t005
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incur short-term costs and require changing patterns of care, we
believe that the data presented here demonstrate the potentially
severe consequences of failing to address the very real and present
threat of nosocomial transmission of TB in South Africa.
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